Drugs & Aging

, Volume 23, Issue 5, pp 377–390

Nursing Home-Acquired Pneumonia

Update on Treatment Options
Therapy In Practice


The management of nursing home-acquired pneumonia (NHAP) continues to be debatable because of the lack of clinical trials and controversy regarding its aetiology. The controversy regarding aetiology stems, in part, from studies that utilised sputum cultures for the diagnosis of NHAP without assessing the quality of the samples. These studies found a high proportion of Gram-negative aerobic bacilli in cultures as well as Staphylococcus aureus. However, in studies that have assessed the reliability of sputum samples, Gram-negative bacilli and S. aureus were isolated infrequently and Streptococcus pneumoniae and Haemophilus influenzae isolated most commonly. Since Gram-negative aerobic bacilli and S. aureus frequently cause hospital-acquired pneumonia, some authors have considered NHAP to be a variant of this group. Many other studies, however, have considered NHAP as part of the community-acquired pneumonia category. Depending on which categorisation is used for NHAP, the treatment recommendations have varied.

There are several factors to consider in the management of NHAP in addition to choice of antibacterial: hospitalisation decision, initial route of administration of antibacterials for treatment in the nursing home, timing of switch from a parenteral to an oral agent and the duration of therapy. These factors, which have not been addressed in published guidelines, are discussed in this review. Recent guidelines recommend a fluoroquinolone (gatifloxacin, levofloxacin or moxifloxacin) or amoxicillin/clavulanic acid plus a macrolide for initial treatment of NHAP in the nursing home. For treatment in the hospital, a parenteral fluoroquinolone (as listed above) or a second- or third-generation cephalosporin plus a macrolide is recommended. A recent guideline for the treatment of healthcare-associated pneumonia (that includes NHAP) recommended an antipseudomonal cephalosporin or a carbapenem or an antipseudomonal penicillin/β-lactamase inhibitor plus ciprofloxacin plus vancomycin or linezolid for treatment of NHAP based on findings in residents with severe pneumonia who required mechanical ventilation. However, this recommendation does not apply to the majority of residents who are hospitalised with pneumonia and not intubated. Other factors to consider when choosing an empiric regimen include recent antibacterial therapy and prior colonisation with a resistant organism, e.g. methicillin-resistant S. aureus.

Recently, a group of studies by investigators in The Netherlands have focused on the concept of withholding antibacterial therapy in nursing home residents with pneumonia who have advanced dementia. These studies are reviewed in some detail because this is an approach to the management of NHAP that is uncommon but deserves more consideration given the terminal status of these people.

Future studies of NHAP should focus on development of rapid (molecular) methods to identify aetiological agents, determination of the optimum antimicrobial regimen and duration of therapy, and identification of criteria that can assist physicians and families in making the decision to withhold antimicrobial therapy in residents with advanced dementia and pneumonia.


  1. 1.
    Mylotte JM. Nursing home-acquired pneumonia. Clin Infect Dis 2002; 35: 1205–11PubMedCrossRefGoogle Scholar
  2. 2.
    Muder RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med 1998; 105: 319–30PubMedCrossRefGoogle Scholar
  3. 3.
    Medina-Walpole AM, Katz PR. Nursing home-acquired pneumonia. J Am Geriatr Soc 1999; 47: 1005–15PubMedGoogle Scholar
  4. 4.
    Marrie TJ. Pneumonia in the long-term care facility. Infect Control Hosp Epidemiol 2002; 23: 159–64PubMedCrossRefGoogle Scholar
  5. 5.
    Loeb M. Pneumonia in older persons. Clin Infect Dis 2003; 37: 1336–9CrossRefGoogle Scholar
  6. 6.
    Janssens JP, Drause KH. Pneumonia in the very old. Lancet Infect Dis 2004; 4(2): 112–24PubMedCrossRefGoogle Scholar
  7. 7.
    Coleman PR. Pneumonia in the long-term care setting: etiology, management, and prevention. J Gerontol Nurs 2004; 30(4): 14–23PubMedGoogle Scholar
  8. 8.
    Furman CD, Rayner AV, Tobin EP. Pneumonia in older residents of long-term care facilities. Am Fam Phys 2004; 70(8): 1495–500Google Scholar
  9. 9.
    Kaikawada M, Iwamoto T, Takasaki M. Aspiration and infection in the elderly: epidemiology, diagnosis, and management. Drugs Aging 2005; 22(2): 115–30CrossRefGoogle Scholar
  10. 10.
    Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243–50PubMedCrossRefGoogle Scholar
  11. 11.
    Zimmer JG, Hall WJ. NHAP: avoiding the hospital. J Am Geriatr Soc 1997; 45: 380–1PubMedGoogle Scholar
  12. 12.
    The British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to the hospital. Br J Hosp Med 1993; 49: 346–50Google Scholar
  13. 13.
    Niederman MS, Bass JB, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am J Respir Crit Care Med 1993; 148: 1418–26Google Scholar
  14. 14.
    Bartlett JG, Breiman RF, Mandell LA, et al. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26: 811–38PubMedCrossRefGoogle Scholar
  15. 15.
    Mandell LA, Marrie TJ, Grosman RF, et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000; 31: 383–421PubMedCrossRefGoogle Scholar
  16. 16.
    Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730–54PubMedGoogle Scholar
  17. 17.
    Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003; 37: 1405–33PubMedCrossRefGoogle Scholar
  18. 18.
    Fein AM. Pneumonia in the elderly: overview of diagnostic and therapeutic approaches. Clin Infect Dis 1999; 28: 726–9PubMedCrossRefGoogle Scholar
  19. 19.
    American Thoracic Society and Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388–416CrossRefGoogle Scholar
  20. 20.
    Marrie TJ, Blanchard W. A comparison of nursing home-acquired pneumonia patients with patients with community-acquired pneumonia and nursing home patients without pneumonia. J Am Geriatr Soc 1997; 45: 50–5PubMedGoogle Scholar
  21. 21.
    Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278: 2080–4PubMedCrossRefGoogle Scholar
  22. 22.
    Lim WS, Macfarlane JT. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 2001; 18: 362–8PubMedCrossRefGoogle Scholar
  23. 23.
    Neill AM, Martin IR, Weir R, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996; 51: 1010–6PubMedCrossRefGoogle Scholar
  24. 24.
    Valenti WM, Trudell RG, Bentley DW. Factors predisposing to oropharyngeal colonization with Gram-negative bacilli in the aged. N Engl J Med 1978; 298: 1108–11PubMedCrossRefGoogle Scholar
  25. 25.
    Nicolle LE, McLeod J, McIntyre M, et al. Significance of pharyngeal colonization with aerobic Gram-negative bacilli in elderly institutionalized men. Age Aging 1986; 15: 47–52CrossRefGoogle Scholar
  26. 26.
    Muder RR, Brennen C, Wagener M, et al. Methicillin-resistant staphylococcal carriage and infection in a long-term care facility. Ann Intern Med 1991; 114: 107–12PubMedGoogle Scholar
  27. 27.
    Verghese A, Berk SL. Bacterial pneumonia in the elderly. Medicine (Baltimore) 1983; 62(5): 271–85Google Scholar
  28. 28.
    Bentley DW, Bradley S, High K, et al. Practice guideline for evaluation of fever and infection in long-term care facilities. Clin Infect Dis 2000; 31: 640–53PubMedCrossRefGoogle Scholar
  29. 29.
    Medina-Walpole AM, McCormick WC. Provider practice patterns in nursing home-acquired pneumonia. J Am Geriatr Soc 1998; 46: 187–96PubMedGoogle Scholar
  30. 30.
    Mylotte JM, Naughton B, Saludades C, et al. Validation and application of the pneumonia prognosis index to nursing home residents with pneumonia. J Am Geriatr Soc 1998; 46: 1538–44PubMedGoogle Scholar
  31. 31.
    Murray PR, Washington JA. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 1975; 50: 339–44PubMedGoogle Scholar
  32. 32.
    Marrie TJ, Durant H, Kwan C. Nursing home-acquired pneumonia: a case-control study. J Am Geriatr Soc 1986; 34: 697–702PubMedGoogle Scholar
  33. 33.
    Peterson PK, Stein D, Guay DRP, et al. Prospective study of lower respiratory tract infections in an extended-care nursing home program: potential role of oral ciprofloxacin. Am J Med 1988; 85: 164–71PubMedCrossRefGoogle Scholar
  34. 34.
    Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 1989; 11: 586–99PubMedCrossRefGoogle Scholar
  35. 35.
    Hirata-Dulas CAI, Stein DJ, Guay DRP, et al. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections. J Am Geriatr Soc 1991; 39: 979–85PubMedGoogle Scholar
  36. 36.
    Drinka PJ, Gauerke C, Voeks S, et al. Pneumonia in a nursing home. J Gen Intern Med 1994; 9: 650–2PubMedCrossRefGoogle Scholar
  37. 37.
    Loeb M, McGeer A, McArthur M, et al. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999; 159: 2058–64PubMedCrossRefGoogle Scholar
  38. 38.
    Gauerke C, Drinka P, Faulks JT, et al. Sputum bacteriology in nursing home pneumonia: a retrospective study. J Am Med Dir Assoc 2001; 2: 285–8PubMedCrossRefGoogle Scholar
  39. 39.
    El-Solh AA, Sikka P, Ramadan F, et al. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 2001; 163: 635–51Google Scholar
  40. 40.
    El-Solh AA, Pietrantoni C, Bhat A, et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med 2003; 167: 1650–4PubMedCrossRefGoogle Scholar
  41. 41.
    Pick N, McDonald A, Bennett NN, et al. Pulmonary aspiration in a long-term care setting: clinical and laboratory observations and an analysis of risk factors. J Am Geriatr Soc 1996; 44: 763–8PubMedGoogle Scholar
  42. 42.
    Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001; 344: 665–71PubMedCrossRefGoogle Scholar
  43. 43.
    Mylotte JM, Goodnough S, Naughton BJ. Pneumonia versus pneumonitis in nursing home residents: diagnosis and management. J Am Geriatr Soc 2003; 51: 17–23PubMedCrossRefGoogle Scholar
  44. 44.
    Mylotte JM, Gould M. Pneumonia versus aspiration pneumonitis in nursing home residents: prospective application of a clinical algorithm. J Am Geriatr Soc 2005; 53: 755–61PubMedCrossRefGoogle Scholar
  45. 45.
    Naughton BJ, Mylotte JM. Treatment guideline for nursing home-acquired pneumonia based on community practice. J Am Geriatr Soc 2000; 48: 82–8PubMedGoogle Scholar
  46. 46.
    Fried TR, Gillick MR, Lipsitz LA. Whether to transfer? Factors associated with hospitalization and outcome of elderly longterm care patients with pneumonia. J Gen Intern Med 1995; 10: 246–50PubMedCrossRefGoogle Scholar
  47. 47.
    Fried TR, Gillick MR, Lipsitz LA. Short-term functional outcomes of long-term care residents with pneumonia treated with and without hospital transfer. J Am Geriatr Soc 1997; 45: 302–6PubMedGoogle Scholar
  48. 48.
    Kruse RL, Mehr DR, Boles KE, et al. Does hospitalization impact survival after lower respiratory tract infection in nursing home residents? Med Care 2004; 42: 860–70PubMedCrossRefGoogle Scholar
  49. 49.
    Hutt E, Kramer AM. Evidence-based guidelines for management of nursing home-acquired pneumonia. J Fam Pract 2002; 51: 709–16PubMedGoogle Scholar
  50. 50.
    Kruse RL, Boles KE, Mehr DR, et al. The cost of treating pneumonia in the nursing home setting. J Am Med Dir Assoc 2003; 4: 81–9PubMedCrossRefGoogle Scholar
  51. 51.
    Brooks S, Harshaw G, Hasse L, et al. The physician decisionmaking process in transferring nursing home patients to the hospital. Arch Intern Med 1994; 154: 902–8PubMedCrossRefGoogle Scholar
  52. 52.
    Cohen-Mansfield J, Lipson S. Medical staff’s decision-making process in the nursing home. J Gerontol A Biol Sci Med Sci 2003; 58: 271–8PubMedCrossRefGoogle Scholar
  53. 53.
    Konetzka T, Spector W, Shaffer T. Effects of nursing home ownership type and resident payor source on hospitalization for suspected pneumonia. Med Care 2004; 42: 1001–8PubMedCrossRefGoogle Scholar
  54. 54.
    Halm EA, Fine MJ, Marrie TJ, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA 1998; 279: 1452–7PubMedCrossRefGoogle Scholar
  55. 55.
    File TM, Niederman MS. Empirical therapy of community-acquired pneumonia. Infect Dis Clin North Am 2004; 18: 993–1016PubMedCrossRefGoogle Scholar
  56. 56.
    Dasgupta M, Boinns MA, Rochon PA. Subcutaneous fluid infusion in a long term care setting. J Am Geriatr Soc 2000; 48: 795–9PubMedGoogle Scholar
  57. 57.
    Vanderkooi OG, Low DE, Green K, et al. Predicting antimicrobial resistance in invasive pneumococcal disease. Clin Infect Dis 2005; 40: 1288–97PubMedCrossRefGoogle Scholar
  58. 58.
    Gleason PP, Meehan TP, Fine JM, et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999; 159: 2562–72PubMedCrossRefGoogle Scholar
  59. 59.
    Giamarellos-Bourboulis EJ, Adamis T, Laoutaris G, et al. Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2004; 48: 93–9PubMedCrossRefGoogle Scholar
  60. 60.
    Choi J-H, Song M-J, Kim S-H, et al. Effect of moxifloxacin on production of proinflammatory cytokines from human peripheral blood mononuclear cells. Antimicrob Agents Chemother 2003; 47: 3704–7PubMedCrossRefGoogle Scholar
  61. 61.
    Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164: 637–44PubMedCrossRefGoogle Scholar
  62. 62.
    Hutt E, Frederickson EB, Ecord M, et al. Processes of care predict survival following nursing home-acquired pneumonia. J Clin Outcomes Manag 2002; 9: 249–56Google Scholar
  63. 63.
    Hutt E, Reznickova N, Morgenstern N, et al. Improving care for nursing home-acquired pneumonia in a managed care environment. Am J Manag Care 2004; 10: 681–6PubMedGoogle Scholar
  64. 64.
    Beard CM, Kokmen E, Sigler C, et al. Cause of death in Alzheimer’s disease. Ann Epidemiol 1996; 6: 195–200PubMedCrossRefGoogle Scholar
  65. 65.
    Keene J, Hope T, Fairburn CG, et al. Death and dementia. Int J Geriatr Psychiatry 2001; 16: 969–74PubMedCrossRefGoogle Scholar
  66. 66.
    Brandt HE, Deliens L, Ooms ME, et al. Symptoms, signs, problems, and diseases of terminally ill nursing home patients. Arch Intern Med 2005; 165: 314–20PubMedCrossRefGoogle Scholar
  67. 67.
    van der Steen JT, Ooms ME, Mehr DR, et al. Severe dementia and adverse outcomes of nursing home-acquired pneumonia: evidence for medication by functional and pathophysiological decline. J Am Geriatr Soc 2002; 50: 439–48PubMedCrossRefGoogle Scholar
  68. 68.
    Morrison RS, Siu AL. Survival in end-stage dementia following acute illness. JAMA 2000; 284: 47–52PubMedCrossRefGoogle Scholar
  69. 69.
    Hertogh CMPM, Ribbe MW. Ethical aspects of medical decision-making in demented patients: a report from the Netherlands. Alzheimer Dis Assoc Disord 1996; 10: 11–9PubMedGoogle Scholar
  70. 70.
    van der Steen JT, Kruse RL, Ooms ME, et al. Treatment of nursing home residents with dementia and lower respiratory tract infection in the United States and the Netherlands: an ocean apart. J Am Geriatr Soc 2004; 52: 691–9PubMedCrossRefGoogle Scholar
  71. 71.
    van der Steen JT, Ooms ME, Ader HJ, et al. Withholding antibiotic treatment in pneumonia patients with dementia. Arch Intern Med 2002; 162: 1753–60PubMedCrossRefGoogle Scholar
  72. 72.
    van der Steen JT, Ooms ME, van der Wal G, et al. Pneumonia: the demented patient’s best friend? Discomfort after starting or withholding antibiotic treatment. J Am Geriatr Soc 2002; 50: 1681–8PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2006

Authors and Affiliations

  1. 1.Departments of Medicine and Microbiology, School of Medicine and Biomedical SciencesState University of New York at BuffaloBuffaloUSA
  2. 2.Department of MedicineErie County Medical CenterBuffaloUSA
  3. 3.Erie County Medical CenterBuffaloUSA

Personalised recommendations